±èµµ¿µ ¸íÀÇ

ȯÀÚÀÇ ¸¶À½±îÁö Ä¡À¯ÇÏ´Â º£Ã¼Æ®º´°ú Å»¸ð ºÐ¾ß ±ÇÀ§ÀÚ

±èµµ¿µ ¸íÀÇ

  • ¼Ò ¼Ó
    ¿¬¼¼´ë¼¼ºê¶õ½ºº´¿ø ÇǺΰú
  • Àü¹®ºÐ¾ß
    º£Ã¼Æ®º´, ±¸°­Á¡¸·Áúȯ, Å»¸ð, ¾à¹°¹ßÁø

±èµµ¿µ ±³¼ö´Â ¼¼ºê¶õ½ºº´¿ø ÇǺΰú ±³¼ö·Î, ÁÖ¿ä Áø·á ºÐ¾ß´Â º£Ã¼Æ®º´, ±¸°­Á¡¸·Áúȯ, Å»¸ð, ¾à¹°¹ßÁø µîÀÌ´Ù. ±è ±³¼ö´Â '¾Æ´Â ¸¸Å­ º¸ÀδÙ'¶ó´Â Áø·áöÇÐÀ» ¹ÙÅÁÀ¸·Î º£Ã¼Æ®º´, Å»¸ð, ¾à¹°¹ßÁø µî Àü¹® ºÐ¾ß¿¡ ´ëÇÑ ²÷ÀÓ¾ø´Â ¿¬±¸¸¦ ¼öÇàÇϰí ÀÖ´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀ¸·Î ȯÀڵ鿡°Ô ÃÖ¼±ÀÇ Ä¡·á¸¦ Á¦°øÇϰí ÀÖ´Ù. ±è±³¼ö´Â ´ëÇÑÇǺΰúÇÐȸ Á¤È¸¿øÀ¸·Î Ȱµ¿Çϰí ÀÖÀ¸¸ç ´ëÇÑÇǺבּ¸ÇÐȸ, ´ëÇѺ£Ã¼Æ®º´ÇÐȸ, ´ëÇѸð¹ßÇÐȸ µî¿¡¼­´Â »óÀÓÀ̻縦 ¿ªÀÓÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¿¬¼¼´ë ÀÇ´ë Çлç (1997 ~ 2003)
  • ¿¬¼¼´ë ÀÇ´ë ¼®»ç (2005 ~ 2007)
  • ¿¬¼¼´ë ÀÇ´ë ¹Ú»ç (2011 ~ 2017)

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¿¬¼¼ÀÇ´ë ÇǺΰúÇб³½Ç ±³¼ö
  • ¿¬¼¼ÀÇ´ë ÇǺΰúÇб³½Ç ºÎ±³¼ö (2019 ~ 2024)
  • ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH) ÇØ¿Ü¿¬¼ö (2017 ~ 2019)
  • ¿¬¼¼ÀÇ´ë ÇǺΰúÇб³½Ç Á¶±³¼ö (2014 ~ 2019)
  • ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø ÇǺΰú ÀÓ»óÁ¶±³¼ö (2012 ~ 2014)
  • ¿¬¼¼ÀÇ´ë ÇǺΰúÇб³½Ç °­»ç (2011 ~ 2012)
  • Çѱ¹ÇѼ¾º¹ÁöÇùȸ °øÁߺ¸°ÇÀÇ»ç (2008 ~ 2011)

¼ö»ó³»¿ª

Awards List
  • ´ëÇÑÇǺΰúÇÐȸ µ¿¾ÆÇмú»ó (2020)

ÇÐȸȰµ¿

Academic activities
  • 2008 ~ ÇöÀç´ëÇÑÇǺΰúÇÐȸ Á¤È¸¿ø
  • 2019 ~ ÇöÀç´ëÇÑÇǺבּ¸ÇÐȸ »óÀÓÀÌ»ç (Çмú°£»ç, À繫ÀÌ»ç, ±âȹÀÌ»ç)
  • 2019 ~ ÇöÀç´ëÇѺ£Ã¼Æ®º´ÇÐȸ »óÀÓÀÌ»ç (À繫ÀÌ»ç)
  • 2019 ~ ÇöÀç´ëÇѸð¹ßÇÐȸ »óÀÓÀÌ»ç (°£ÇàÁ¤º¸ÀÌ»ç, ÇмúÀÌ»ç)
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 5°Ç
Á¦ ¸ñ Å»¸ðÇÐ
ÃâÆÇ»ç Á¤¿ìÀÇÇм­Àû ¹ßÇàÀÏ 2021
Á¦ ¸ñ KIM's Dermatology
ÃâÆÇ»ç Á¤¿ìÀÇÇм­Àû ¹ßÇàÀÏ 2025
Á¦ ¸ñ Behçet¡¯s Disease: Progress in Recent Years and Unmet Needs for the Future
ÃâÆÇ»ç Nova Science Publishers ¹ßÇàÀÏ 2015
Á¦ ¸ñ Atlas of Inflammatory Bowel Diseases
ÃâÆÇ»ç Springer ¹ßÇàÀÏ 2015
Á¦ ¸ñ Behçet¡¯s Disease in Korea
ÃâÆÇ»ç ÇÏ´©¸® ¹ßÇàÀÏ 2013
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö Nature Medicine
Á¦ ¸ñ Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö Journal of Clinical Investigation
Á¦ ¸ñ Core Gene Signatures of Atopic Dermatitis Using Public RNA-Sequencing Resources: Comparison of Bulk Approach with Single-Cell Approach
¹ßÇ¥³âµµ 2022 ¹ßÇ¥Áö Journal of Investigative Dermatology
Á¦ ¸ñ Application of single-cell RNA sequencing on human skin: Technical evolution and challenges
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö Journal of Dermatological Science
Á¦ ¸ñ Trial of apremilast for oral ulces in Behçet's syndrome
¹ßÇ¥³âµµ 2019 ¹ßÇ¥Áö New England Journal of Medicine
Á¦ ¸ñ Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium
¹ßÇ¥³âµµ 2019 ¹ßÇ¥Áö Cell
Á¦ ¸ñ Non-thermal atmospheric pressure plasma activates Wnt/¥â-catenin signaling in dermal papilla cells
¹ßÇ¥³âµµ 2021 ¹ßÇ¥Áö Scientific Reports

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

´Ù¾çÇÑ Àü½ÅÁõ»ó°ú µ¿¹ÝµÈ ÇǺÎÁ¡¸·, ºÎ¼Ó±âÀÇ Ä§¹ü¿¡ ´ëÇØ ¸é¿ªÇÐÀûÀ¸·Î ¿¬±¸ÇÏ°í °ü·ÃÁúȯÀ» Áø·áÇϴµ¥ Çй®ÀûÀÎ °ü½ÉÀÌ ¸¹½À´Ï´Ù. ƯÈ÷ ´Ù¾çÇÑ Àå±âÁúȯÀ» ħ¹üÇϸ鼭 ±¸°­±Ë¾çÀÌ ½ÉÇÑ º£Ã¼Æ®º´°ú ÀÚ°¡¸é¿ª±âÀüÀÇ Å»¸ð°¡ ÀϾ´Â ¿øÇüÅ»¸ð¿¡ ´ëÇØ ¿¬±¸¿Í Áø·á¸¦ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇǺÎÁ¡¸·À» Àß Ä§¹üÇÏ´Â ÁßÁõ¾à¹°¹ßÁøÀÇ Áø´Ü¹ý °³¹ß¿¡µµ ¿¬±¸¸¦ º´ÇàÇϰí ÀÖ¾î, ÁßÁõ¾àÁøÈ¯ÀÚÀÇ Áø·áµµ ´ã´çÇϰí ÀÖ½À´Ï´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

´Ù¸¥ Áúȯµµ ¸¶Âù°¡Áö°ÚÁö¸¸, »õ·Î¿î ¿¬±¸¼º°úµéÀÌ ¸é¿ªÇǺÎÁúȯ¿¡¼­´Â °è¼Ó ¾÷µ¥ÀÌÆ® µÇ°í ÀÖ°í, ÁúȯÁ¤Àǵµ °è¼Ó ´Þ¶óÁö°í ÀÖ½À´Ï´Ù. "¾Æ´Â¸¸Å­ º¸ÀδÙ"´Â Áø·áöÇеµ »õ·Î¿î Áö½Ä¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¾÷µ¥ÀÌÆ®°¡ ÀÌ·ç¾îÁ®¾ß Áø·áÀÇ ¿ª·®µµ ³ô¾ÆÁø´Ù°í »ý°¢ÇÕ´Ï´Ù. ¶ÇÇÑ Áß¿äÇÑ ÀÓ»ó Á¤º¸´Â ȯÀÚ¿¡°Ô¼­ ³ª¿À´Â °ÍÀ¸¹Ç·Î ȯÀÚ°¡ Á¦°øÇÏ´Â Á¤º¸¸¦ Áø·á½Ã°£¿¡ °¡±ÞÀû ¸¹ÀÌ °æÃ»ÇϰíÀÚ ÇÕ´Ï´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

º£Ã¼Æ®º´À̳ª ¿øÇüÅ»¸ð´Â ´Ü±â°£ Ä¡·á¿¡ ±Ý¹æ ¿ÏÄ¡µÇ´Â º´ÀÌ ¾Æ´Ï°í ÄÁµð¼Ç¿¡ µû¶ó ¸¸¼ºÀûÀ¸·Î Àç¹ßÇÏ´Â ÁúȯÀÔ´Ï´Ù. Áõ»ó¾ÇÈ­¿¡ µû¸¥ Èûµë°ú ÁÂÀýÀÌ ÀÖ°ÚÁö¸¸ ±Þ¼º±â¸¦ Àß º¸³»°í ÀûÀýÇÑ ¾àÁ¦°¡ Àß À¯ÁöµÈ´Ù¸é Áõ»óÀÇ Å« Àç¹ß¾øÀÌ °ü¸®°¡ °¡´ÉÇÑ ÁúȯµéÀÔ´Ï´Ù. ÁúȯÀÇ °æ°ú¸¦ ±æ°Ôº¸°í ¸Õ±æ ³¡¿¡´Â ¸¶¶óÅæÀÇ µµÂøÁ¡ÀÌ ÀÖµíÀÌ ¼­¼­È÷ È£ÀüµÈ´Ù´Â ¹ÏÀ½À» °®°í °Ç°­°ü¸®¸¦ °°ÀÌ ÇØ³ª°©½Ã´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¿¬¼¼´ë¼¼ºê¶õ½ºº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1599-1004

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¿¬¼¼´ë¼¼ºê¶õ½ºº´¿øÀº 1885³â H.N.¾Ë·»ÀÌ ¼¼¿î ¿ì¸®³ª¶ó ÃÖÃÊÀÇ ¼­¾ç½Ä º´¿øÀÎ Á¦Áß¿ø(±¤Çý¿ø)À¸·Î ⸳µÈ ÀÌ·¡ 130³â µ¿¾È ÃÖ°íÀÇ Ã·´Ü ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀÌ´Ù. ±¹³» ÃÖÃÊ·Î Áø·áÀÇ Àü¹®È­¸¦ ÅëÇÑ ÀÇ·áÀÇ Áú Çâ»óÀ» À§ÇØ ÀçȰº´¿ø, ½ÉÀåÇ÷°üº´¿ø, ¾È.À̺ñÀÎÈİúº´¿ø, ¾î¸°À̺´¿ø°ú ÀÀ±ÞÁø·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹®¼¾ÅÍ, ¾ÏÀü¹®Å¬¸®´ÐÀ» ¿î¿µÇϰí ÀÖ´Ù.

¿¬¼¼´ë¼¼ºê¶õ½ºº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¼­´ë¹®±¸ ¿¬¼¼·Î 50-1

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä